Sustained contributor to HBP SGA1, HBP SGA2, and ICEI, providing neuroinformatics, brain reconstruction, and high-performance computing capabilities.
DEBRECENI EGYETEM
Hungarian research university combining neuroscience, molecular medicine, and agricultural sustainability with strong bioinformatics and open science infrastructure expertise.
Their core work
The University of Debrecen is a major Hungarian research university with deep strengths in life sciences, neuroscience, and agricultural research. They contribute bioinformatics, genomics, and brain simulation expertise to large European consortia, notably as a sustained partner in the Human Brain Project. Their applied work spans rural development, livestock breeding efficiency, and open science infrastructure, making them a versatile academic partner bridging molecular-level research with food system and societal challenges.
What they specialise in
Core participant in OpenAIRE2020, OpenAIRE-Advance, NI4OS-Europe, and EOSC-related projects building open access monitoring and research information systems.
Involved in HU-MOLMEDEX, HCEMM (EMBL partnership), pHioniC (pancreatic cancer), MICROB-PREDICT (liver cirrhosis), and Bio4Med doctoral programme.
Partner in SMARTER (small ruminant breeding), RURALIZATION, DESIRA (rural digitisation), and CERERE (cereal diversity in organic farming).
Contributed to CoSIE (service co-creation), INTEGRITY (research conduct training), EnTIRE (ethics mapping), and ACCOMPLISSH (SSH impact).
Participated in Feel4Diabetes, PRECIOUS (stroke prevention), EUthyroid, and GLORIA (glucocorticoid treatment).
How they've shifted over time
In the early H2020 period (2014–2017), the university focused on molecular medicine, personalised health, and building open access research infrastructure — projects like HU-MOLMEDEX, PRECeDI, and OpenAIRE2020 defined this phase. From 2018 onward, their profile shifted markedly toward computational neuroscience (HBP SGA2, ICEI) and rural/agricultural sustainability (SMARTER, RURALIZATION, DESIRA), reflecting a broadening from bench science into data-intensive and societal-impact research. The emergence of bioinformatics and high-performance computing as recurring keywords signals a growing computational identity.
Moving toward computationally intensive life science and agricultural digitisation — expect future proposals combining bioinformatics with food systems or precision livestock.
How they like to work
The University of Debrecen is almost exclusively a consortium partner (36 of 38 projects), with only one coordinator role (ECECWorkforce). They operate comfortably in large, multi-country consortia — 569 unique partners across 48 countries — which signals reliability and adaptability rather than project leadership ambitions. Their modest per-project funding (avg EUR 125K) and broad topic range suggest they contribute specialised expertise modules to larger efforts rather than driving the research agenda.
With 569 unique consortium partners spanning 48 countries, the University of Debrecen maintains one of the broadest collaboration networks among Hungarian universities. Their partnerships are pan-European with no narrow geographic cluster, though Central and Western European institutions dominate.
What sets them apart
What sets the University of Debrecen apart is the rare combination of Human Brain Project neuroscience expertise with strong agricultural and rural development capabilities — few universities bridge these domains. Their sustained involvement in Hungary's Centre of Excellence for Molecular Medicine (HCEMM, in partnership with EMBL) gives them direct access to top-tier European molecular biology networks. For consortium builders, they offer a reliable Hungarian partner with genuine research depth across life sciences, not just Widening Participation filler.
Highlights from their portfolio
- HBP SGA1 / HBP SGA2Multi-year participation in the EU Flagship Human Brain Project, contributing neuroinformatics, brain transcriptome analysis, and simulation work.
- MICROB-PREDICTLargest single EC contribution (EUR 347K) — microbiome-based biomarkers for liver disease, combining multi-omics and nanobiosensor expertise.
- HCEMMEstablishing Hungary's Centre of Excellence for Molecular Medicine in partnership with EMBL — a long-term structural investment (2017–2025) raising Hungarian research capacity.